[go: up one dir, main page]

Chelation Therapy

"Chelation Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.


expand / collapse Publications
This graph shows the total number of publications written about "Chelation Therapy" by people in this website by year, and whether "Chelation Therapy" was a major or minor topic of these publications.
Below are the most recent publications written about "Chelation Therapy" by people in Profiles.
  1. Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia. Hematol Oncol Clin North Am. 2023 04; 37(2):393-411.
    View in: PubMed
  2. Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study. Lancet Glob Health. 2022 01; 10(1):e134-e141.
    View in: PubMed
  3. A complication risk score to evaluate clinical severity of thalassaemia syndromes. Br J Haematol. 2021 02; 192(3):626-633.
    View in: PubMed
  4. Thalassemia: Common Clinical Queries in Management. Indian J Pediatr. 2020 01; 87(1):75-81.
    View in: PubMed
  5. Haemochromatosis. Nat Rev Dis Primers. 2018 04 05; 4:18016.
    View in: PubMed
  6. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype. Hepatol Int. 2018 Mar; 12(2):83-86.
    View in: PubMed
  7. Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents. Sci Rep. 2018 03 13; 8(1):4419.
    View in: PubMed
  8. Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach. Eur Heart J Cardiovasc Imaging. 2018 03 01; 19(3):299-309.
    View in: PubMed
  9. How we manage iron overload in sickle cell patients. Br J Haematol. 2017 06; 177(5):703-716.
    View in: PubMed
  10. Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST). Pediatr Blood Cancer. 2017 Sep; 64(9).
    View in: PubMed